A review of back-calculation techniques and their potential to inform mitigation strategies with application to non-transmissible acute infectious diseases.

Joseph R Egan, Ian M Hall
Author Information

Abstract

Back-calculation is a process whereby generally unobservable features of an event leading to a disease outbreak can be inferred either in real-time or shortly after the end of the outbreak. These features might include the time when persons were exposed and the source of the outbreak. Such inferences are important as they can help to guide the targeting of mitigation strategies and to evaluate the potential effectiveness of such strategies. This article reviews the process of back-calculation with a particular emphasis on more recent applications concerning deliberate and naturally occurring aerosolized releases. The techniques can be broadly split into two themes: the simpler temporal models and the more sophisticated spatio-temporal models. The former require input data in the form of cases' symptom onset times, whereas the latter require additional spatial information such as the cases' home and work locations. A key aspect in the back-calculation process is the incubation period distribution, which forms the initial topic for consideration. Links between atmospheric dispersion modelling, within-host dynamics and back-calculation are outlined in detail. An example of how back-calculation can inform mitigation strategies completes the review by providing improved estimates of the duration of antibiotic prophylaxis that would be required in the response to an inhalational anthrax outbreak.

References

  1. Epidemiol Infect. 2007 Oct;135(7):1145-50 [PMID: 17156499]
  2. Med Decis Making. 2008 Jul-Aug;28(4):593-605 [PMID: 18556642]
  3. Biosecur Bioterror. 2011 Dec;9(4):331-43 [PMID: 22044315]
  4. BMC Infect Dis. 2006;6:147 [PMID: 17026751]
  5. Science. 2002 Mar 8;295(5561):1861 [PMID: 11884746]
  6. J Theor Biol. 2012 Feb 7;294:48-55 [PMID: 22079419]
  7. Enferm Infecc Microbiol Clin. 2008 Jan;26(1):15-22 [PMID: 18208761]
  8. Pharmacoepidemiol Drug Saf. 2008 May;17(5):523-32 [PMID: 18215001]
  9. Lancet Infect Dis. 2005 Apr;5(4):219-26 [PMID: 15792739]
  10. Stat Med. 1991 Oct;10(10):1527-42 [PMID: 1947509]
  11. Stat Med. 2005 Feb 28;24(4):531-42 [PMID: 15678407]
  12. J Natl Cancer Inst. 1988 Aug 17;80(12):900-11 [PMID: 3294425]
  13. Int J Epidemiol. 1999 Apr;28(2):353-9 [PMID: 10342703]
  14. Science. 1994 Nov 18;266(5188):1202-8 [PMID: 7973702]
  15. Stat Methods Med Res. 2003 Jun;12(3):177-90 [PMID: 12828240]
  16. Epidemiol Infect. 2014 Aug;142(8):1763-77 [PMID: 24112310]
  17. Am J Hyg. 1950 May;51(3):310-8 [PMID: 15413610]
  18. PLoS Med. 2013 Oct;10(10):e1001540 [PMID: 24204214]
  19. Am J Epidemiol. 2003 Jul 15;158(2):110-7 [PMID: 12851223]
  20. Stat Med. 2009 Sep 30;28(22):2769-84 [PMID: 19598148]
  21. Epidemiology. 2011 Mar;22(2):188-98 [PMID: 21242803]
  22. Biostatistics. 2001 Jun;2(2):233-47 [PMID: 12933552]
  23. Emerg Infect Dis. 2004 Jul;10(7):1202-5 [PMID: 15324538]
  24. Ann Intern Med. 2006 Feb 21;144(4):270-80 [PMID: 16490913]
  25. Epidemiol Infect. 2007 Jan;135(1):126-30 [PMID: 16684403]
  26. Med Decis Making. 2011 Jan-Feb;31(1):69-78 [PMID: 20484093]
  27. Emerg Themes Epidemiol. 2007 May 11;4:2 [PMID: 17466070]
  28. Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):10129-32 [PMID: 12890865]
  29. J Hazard Mater. 2010 Nov 15;183(1-3):474-81 [PMID: 20716470]
  30. BMC Infect Dis. 2010;10:69 [PMID: 20230650]
  31. Science. 2001 Nov 23;294(5547):1729-31 [PMID: 11679631]
  32. Theor Biol Med Model. 2010;7:39 [PMID: 20973955]
  33. Radiat Prot Dosimetry. 2005;113(1):75-89 [PMID: 15572402]
  34. Emerg Infect Dis. 2004 Apr;10(4):608-14 [PMID: 15200849]
  35. Euro Surveill. 2010 Mar 25;15(12). pii: 19521 [PMID: 20350497]
  36. Clin Microbiol Infect. 2006 Jul;12(7):642-7 [PMID: 16774560]
  37. Epidemics. 2010 Dec;2(4):189-94 [PMID: 21352789]
  38. Euro Surveill. 2012;17(49). pii: 20331 [PMID: 23231895]
  39. Nature. 2004 Dec 16;432(7019):901-4 [PMID: 15602561]
  40. PLoS Pathog. 2013 Aug;9(8):e1003555 [PMID: 24058320]
  41. Nature. 2000 Aug 10;406(6796):583-4 [PMID: 10949288]
  42. Stat Med. 2013 Sep 10;32(20):3522-38 [PMID: 23483594]
  43. Clin Infect Dis. 2012 Dec;55(12):1591-9 [PMID: 22918992]
  44. Environ Sci Technol. 2005 Apr 15;39(8):2736-43 [PMID: 15884371]
  45. Emerg Infect Dis. 2003 Aug;9(8):915-21 [PMID: 12967487]
  46. PLoS Comput Biol. 2009 Jan;5(1):e1000356 [PMID: 19360099]
  47. BMC Med Inform Decis Mak. 2009;9 Suppl 1:S7 [PMID: 19891801]
  48. Biosecur Bioterror. 2005;3(4):348-56 [PMID: 16366844]
  49. Epidemiology. 2007 Mar;18(2):253-9 [PMID: 17235210]
  50. Int J Tuberc Lung Dis. 2002 Sep;6(9):831-8 [PMID: 12234140]
  51. J Infect Dis. 2006 Jan 1;193(1):102-11 [PMID: 16323138]
  52. J R Soc Interface. 2014 Jun 6;11(95):20140119 [PMID: 24671937]
  53. Am J Epidemiol. 2013 Sep 15;178(6):984-92 [PMID: 23935124]
  54. Proc Biol Sci. 1999 Jan 7;266(1414):23-32 [PMID: 10081155]
  55. Stat Med. 2005 Aug 30;24(16):2525-37 [PMID: 16013037]
  56. Epidemiol Infect. 2008 Jun;136(6):823-32 [PMID: 17662166]
  57. Biometrics. 1996 Sep;52(3):781-96 [PMID: 8805756]
  58. Int J Hyg Environ Health. 2009 Jan;212(1):97-104 [PMID: 18178524]
  59. Am J Epidemiol. 1989 Sep;130(3):557-68 [PMID: 2764000]
  60. Nihon Koshu Eisei Zasshi. 1998 Feb;45(2):129-41 [PMID: 9611993]
  61. Nature. 2001 Dec 13;414(6865):748-51 [PMID: 11742399]
  62. Med Decis Making. 2009 Jul-Aug;29(4):424-37 [PMID: 19617582]
  63. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4346-51 [PMID: 12651951]
  64. Nature. 1996 Aug 29;382(6594):779-88 [PMID: 8752271]
  65. Radiat Prot Dosimetry. 2004;111(3):257-69 [PMID: 15266085]
  66. Commun Dis Public Health. 1998 Sep;1(3):180-7 [PMID: 9782633]
  67. Am J Epidemiol. 1984 Mar;119(3):382-91 [PMID: 6702814]
  68. Stat Med. 1989 Jan;8(1):23-34 [PMID: 2919244]
  69. Clin Infect Dis. 2008 Jan 1;46(1):61-9 [PMID: 18171215]
  70. Ann Intern Med. 2005 Apr 19;142(8):601-10 [PMID: 15838066]
  71. Stat Med. 2011 Jan 30;30(2):101-26 [PMID: 20963771]
  72. BMC Infect Dis. 2013;13:11 [PMID: 23305174]
  73. Science. 2001 Nov 23;294(5547):1726-8 [PMID: 11721058]
  74. Stat Med. 2007 Dec 20;26(29):5225-52 [PMID: 17948918]
  75. Lancet Infect Dis. 2009 May;9(5):291-300 [PMID: 19393959]
  76. Nature. 1997 Jan 16;385(6613):197-8 [PMID: 9000063]
  77. Biostatistics. 2011 Apr;12(2):303-12 [PMID: 20858771]
  78. Am J Epidemiol. 1966 Mar;83(2):204-6 [PMID: 5930773]
  79. PLoS One. 2014;9(1):e86568 [PMID: 24466153]
  80. Epidemiol Infect. 2011 Sep;139(9):1418-24 [PMID: 21087539]
  81. Proc Natl Acad Sci U S A. 2006 May 16;103(20):7589-94 [PMID: 16679412]
  82. J R Soc Med. 2012 Feb;105(2):66-73 [PMID: 22357982]
  83. Euro Surveill. 2012;17(28). pii: 20216 [PMID: 22835439]

MeSH Term

Animals
Communicable Disease Control
Communicable Diseases
Computer Simulation
Disease Outbreaks
Feasibility Studies
Humans
Incidence
Models, Statistical
Population Surveillance
Risk Assessment
Spatio-Temporal Analysis

Word Cloud

Created with Highcharts 10.0.0back-calculationoutbreakcanstrategiesprocessmitigationfeaturespotentialtechniquesmodelsrequirecases'informreviewBack-calculationwherebygenerallyunobservableeventleadingdiseaseinferredeitherreal-timeshortlyendmightincludetimepersonsexposedsourceinferencesimportanthelpguidetargetingevaluateeffectivenessarticlereviewsparticularemphasisrecentapplicationsconcerningdeliberatenaturallyoccurringaerosolizedreleasesbroadlysplittwothemes:simplertemporalsophisticatedspatio-temporalformerinputdataformsymptomonsettimeswhereaslatteradditionalspatialinformationhomeworklocationskeyaspectincubationperioddistributionformsinitialtopicconsiderationLinksatmosphericdispersionmodellingwithin-hostdynamicsoutlineddetailexamplecompletesprovidingimprovedestimatesdurationantibioticprophylaxisrequiredresponseinhalationalanthraxapplicationnon-transmissibleacuteinfectiousdiseases

Similar Articles

Cited By